LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.66 USD -2.35% Market Closed
Market Cap: 43.6m USD
Have any thoughts about
LAVA Therapeutics NV?
Write Note

LAVA Therapeutics NV
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LAVA Therapeutics NV
Operating Income Peer Comparison

Comparables:
PHARM
PRQR
QURE
ARGX
MRUS

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Operating Income
-$43.3m
CAGR 3-Years
-43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Operating Income
-$16.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-5%
ProQR Therapeutics NV
NASDAQ:PRQR
Operating Income
-€25.3m
CAGR 3-Years
19%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Operating Income
-$194.7m
CAGR 3-Years
N/A
CAGR 5-Years
-12%
CAGR 10-Years
-17%
argenx SE
XBRU:ARGX
Operating Income
-$432.1m
CAGR 3-Years
-13%
CAGR 5-Years
-25%
CAGR 10-Years
-57%
Merus NV
NASDAQ:MRUS
Operating Income
-$231m
CAGR 3-Years
-37%
CAGR 5-Years
-43%
CAGR 10-Years
N/A

See Also

What is LAVA Therapeutics NV's Operating Income?
Operating Income
-43.3m USD

Based on the financial report for Dec 31, 2023, LAVA Therapeutics NV's Operating Income amounts to -43.3m USD.

What is LAVA Therapeutics NV's Operating Income growth rate?
Operating Income CAGR 3Y
-43%

Over the last year, the Operating Income growth was -24%. The average annual Operating Income growth rates for LAVA Therapeutics NV have been -43% over the past three years .

Back to Top